Lithuanian University of Health Sciences
Kaunas, Lithuania
NCT Number: NCT02894372
The purpose of the study was to assess the effectiveness of Faringomoss in reducing the throat discomfort and pain in patients with acute throat diseases and postoperative patients after throat surgeries.
Looking for future studies?
Notify Me6 year and older
All sexes
Interventional
Not applicable
Kaunas, Lithuania
Study objectives were:
Patients were selected from Lithuanian University of Health Sciences Ear-Nose-Throat department and Vita Longa Clinic outpatients.
In random order research participants got a topical spray to use for 7 days after the surgery or from the start of acute throat infection. Neither the patient nor the investigator did not know if it was the medical device (Faringomoss) or the placebo. All the participants got a standard care and treatment with non-steroidal anti-inflammatory drugs.
The intent was to investigate about 70 - 80 subjects.
All the research subjects were tested using objective methods.
The confidentiality of the participation was guaranteed. The names were anonymous. The results were summarized.
Faringomoss is a topical spray, approved as a medical device. It is not harmful because it is made of vegetable oils.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Research participants got topical oral spray immediately after surgery (hospital patients) and from the first doctor visit with pharyngeal disease (clinic outpatients).
Research participants got topical oral spray immediately after surgery (hospital patients) and from the first doctor visit with pharyngeal disease (clinic outpatients).
Time frame: The first, third, fifth and seventh treatment days
Scale assessment: 0 point - no symptom, 100 points - strong symptom manifestation. Evaluated symptoms are: throat pain, ear pain, swallowing pain, difficult mouth opening, difficult swallowing, impaired nutrition, general condition, how symptoms are effecting life. If additional symptoms occur during investigation period, they are assessed too.
Time frame: After 7 days of treatment
Mucosal erythema, swelling, erosion, fibrin plaque, fistulas are evaluated using three points (0-2) Likert scale.
Time frame: Up to 7 days
We note if there was a bleeding after throat surgery during investigation time.
Time frame: Up to 7 days
We evaluate the amount of used standardized analgesics/anti-inflammatory drugs.
Time frame: Up to 7 days
We measure how many days or hours it took for the patient to notice the effect of the medical device.
Lithuanian University of Health Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00540774
Gingival Diseases, Gingivitis
Irvine, California, United States
View Trial DetailsNCT06888453
Gingival Diseases, Gingivitis
Baghdad, Iraq
View Trial DetailsNCT06792812
Bleeding Gum, Gingival Diseases
Baghdad, Iraq
View Trial DetailsNCT05787600
Bleeding Gum, Gingival Diseases
Baghdad, Bab Al-Moadham, Iraq
View Trial Details